amikacin has been researched along with rifamycins in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (42.86) | 18.7374 |
1990's | 3 (42.86) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Cynamon, MH; DeStefano, MS; Klemens, SP | 1 |
Bollet, C; de Micco, P; Gevaudan, MJ; Gulian, C; Mallet, MN | 1 |
Gangadharam, PR; Iseman, MD; Kesavalu, L; Perumal, VK; Podapati, NR | 1 |
Dauchy, P; Varlet, A | 1 |
Jorup-Rönström, C; Julander, I; Petrini, B | 1 |
Hjelm, U; Hoffner, SE; Källenius, G | 1 |
Brode, SK; Carlson, KF; Henkle, E; Ku, JH; Marino, M; Marras, TK; Winthrop, KL | 1 |
7 other study(ies) available for amikacin and rifamycins
Article | Year |
---|---|
Activity of clarithromycin against Mycobacterium avium complex infection in beige mice.
Topics: Amikacin; Animals; Anti-Infective Agents; Antitubercular Agents; Clarithromycin; Clofazimine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; Humans; Mice; Mice, Inbred C57BL; Mycobacterium avium; Mycobacterium avium Complex; Quinolones; Rifabutin; Rifampin; Rifamycins; Time Factors; Tuberculosis | 1992 |
[Bacteriostatic and bactericidal study of rifabutine and clofazimine in combination against Mycobacterium avium-intracellulare and Mycobacterium xenopi].
Topics: Amikacin; Ciprofloxacin; Clofazimine; Drug Therapy, Combination; Erythromycin; Humans; Mycobacterium; Mycobacterium avium Complex; Rifabutin; Rifamycins | 1989 |
In vivo activity of amikacin alone or in combination with clofazimine or rifabutin or both against acute experimental Mycobacterium avium complex infections in beige mice.
Topics: Amikacin; Animals; Antitubercular Agents; Clofazimine; Drug Therapy, Combination; Male; Mice; Mice, Inbred C57BL; Mycobacterium avium; Rifabutin; Rifamycins; Tuberculosis | 1988 |
[Plaster of Paris pellets containing antibiotics in the treatment of bone infection. New combinations of plaster with antibiotics].
Topics: Amikacin; Anti-Bacterial Agents; Bone and Bones; Calcium Sulfate; Drug Implants; Humans; Kinetics; Netilmicin; Osteomyelitis; Rifampin; Rifamycins | 1983 |
Efficacy of triple drug regimen of amikacin, ethambutol and rifabutin in AIDS patients with symptomatic Mycobacterium avium complex infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Amikacin; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifabutin; Rifamycins | 1993 |
Susceptibility of Mycobacterium malmoense to antibacterial drugs and drug combinations.
Topics: Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium; Rifabutin; Rifampin; Rifamycins | 1993 |
Evaluation of Mycobacterium Avium Complex Pulmonary Disease Treatment Completion and Adherence to ATS/IDSA Guidelines.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung Diseases; Macrolides; Male; Medicare; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifamycins; United States | 2023 |